Need Help?

Canadian prostate cancer samples (CPC-GENE) for PanProstate study

CPC-GENE has sequenced the genomes of 350 intermediate risk prostate cancers to identify genetic signatures that differ in cancers that responded well to treatment compared with those that did not. CPC-GENE also has sequenced multiple regions of prostate cancer from the same gland to determine if and how the genetic make-up of prostate cancer varies within an individual man’s prostate

Publications Citations
Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry.
Nat Commun 16: 2025 8799
0